These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 21822023)
1. Serum S100A12 (EN-RAGE) levels in patients with decreased renal function and subclinical chronic inflammatory disease. Zakiyanov O; Kalousová M; Kříha V; Zima T; Tesař V Kidney Blood Press Res; 2011; 34(6):457-64. PubMed ID: 21822023 [TBL] [Abstract][Full Text] [Related]
2. Relationship of pregnancy-associated plasma protein-a to renal function and dialysis modalities. Fialová L; Kalousová M; Soukupová J; Sulková S; Merta M; Jelínková E; Horejsí M; Srámek P; Malbohan I; Mikulíková L; Tesar V; Zima T Kidney Blood Press Res; 2004; 27(2):88-95. PubMed ID: 14739577 [TBL] [Abstract][Full Text] [Related]
3. Soluble receptor for advanced glycation end products in patients with decreased renal function. Kalousová M; Hodková M; Kazderová M; Fialová J; Tesar V; Dusilová-Sulková S; Zima T Am J Kidney Dis; 2006 Mar; 47(3):406-11. PubMed ID: 16490618 [TBL] [Abstract][Full Text] [Related]
4. Soluble receptor for advanced glycation endproducts is decreased in patients with juvenile idiopathic arthritis (ERA category) and inversely correlates with disease activity and S100A12 levels. Myles A; Viswanath V; Singh YP; Aggarwal A J Rheumatol; 2011 Sep; 38(9):1994-9. PubMed ID: 21724696 [TBL] [Abstract][Full Text] [Related]
5. Circulating levels of soluble receptor for advanced glycation end product are inversely associated with vascular calcification in patients on haemodialysis independent of S100A12 (EN-RAGE) levels. Kim HS; Chung W; Kim AJ; Ro H; Chang JH; Lee HH; Jung JY Nephrology (Carlton); 2013 Dec; 18(12):777-82. PubMed ID: 24124651 [TBL] [Abstract][Full Text] [Related]
6. Plasma S100A12 and soluble receptor of advanced glycation end product levels and mortality in chronic kidney disease Stage 5 patients. Isoyama N; Leurs P; Qureshi AR; Bruchfeld A; Anderstam B; Heimburger O; Bárány P; Stenvinkel P; Lindholm B Nephrol Dial Transplant; 2015 Jan; 30(1):84-91. PubMed ID: 25074436 [TBL] [Abstract][Full Text] [Related]
7. Acute Kawasaki disease is associated with reverse regulation of soluble receptor for advance glycation end products and its proinflammatory ligand S100A12. Wittkowski H; Hirono K; Ichida F; Vogl T; Ye F; Yanlin X; Saito K; Uese K; Miyawaki T; Viemann D; Roth J; Foell D Arthritis Rheum; 2007 Dec; 56(12):4174-81. PubMed ID: 18050248 [TBL] [Abstract][Full Text] [Related]
8. Receptor for advanced glycation end products--soluble form and gene polymorphisms in chronic haemodialysis patients. Kalousová M; Jáchymová M; Mestek O; Hodková M; Kazderová M; Tesar V; Zima T Nephrol Dial Transplant; 2007 Jul; 22(7):2020-6. PubMed ID: 17347281 [TBL] [Abstract][Full Text] [Related]
9. Plasma levels of soluble receptor for advanced glycation end products (sRAGE) and proinflammatory ligand for RAGE (EN-RAGE) are associated with carotid atherosclerosis in patients with peritoneal dialysis. Kim JK; Park S; Lee MJ; Song YR; Han SH; Kim SG; Kang SW; Choi KH; Kim HJ; Yoo TH Atherosclerosis; 2012 Jan; 220(1):208-14. PubMed ID: 21906738 [TBL] [Abstract][Full Text] [Related]
10. EN-RAGE (extracellular newly identified receptor for advanced glycation end-products binding protein) and mortality of long-term hemodialysis patients: A prospective observational cohort study. Kalousová M; Kuběna AA; Benáková H; Dusilová-Sulková S; Tesař V; Zima T Clin Biochem; 2012 May; 45(7-8):556-60. PubMed ID: 22394461 [TBL] [Abstract][Full Text] [Related]
11. S100A12 gene expression is increased in peripheral leukocytes in chronic kidney disease stage 4-5 patients with cardiovascular disease. Hara M; Ando M; Morito T; Nokiba H; Iwasa Y; Tsuchiya K; Nitta K Nephron Clin Pract; 2013; 123(3-4):202-8. PubMed ID: 23921255 [TBL] [Abstract][Full Text] [Related]
12. Associations between Soluble Receptor for Advanced Glycation End Products (sRAGE) and S100A12 (EN-RAGE) with Mortality in Long-term Hemodialysis Patients. Jung ES; Chung W; Kim AJ; Ro H; Chang JH; Lee HH; Jung JY J Korean Med Sci; 2017 Jan; 32(1):54-59. PubMed ID: 27914132 [TBL] [Abstract][Full Text] [Related]
13. Systemic levels of the anti-inflammatory decoy receptor soluble RAGE (receptor for advanced glycation end products) are decreased in dogs with inflammatory bowel disease. Heilmann RM; Otoni CC; Jergens AE; Grützner N; Suchodolski JS; Steiner JM Vet Immunol Immunopathol; 2014 Oct; 161(3-4):184-92. PubMed ID: 25183017 [TBL] [Abstract][Full Text] [Related]
14. Peripheral RAGE (receptor for advanced glycation endproducts)-ligands in normal pregnancy and preeclampsia: novel markers of inflammatory response. Naruse K; Sado T; Noguchi T; Tsunemi T; Yoshida S; Akasaka J; Koike N; Oi H; Kobayashi H J Reprod Immunol; 2012 Mar; 93(2):69-74. PubMed ID: 22382005 [TBL] [Abstract][Full Text] [Related]
15. Soluble RAGE and the RAGE ligands HMGB1 and S100A12 in critical illness: impact of glycemic control with insulin and relation with clinical outcome. Ingels C; Derese I; Wouters PJ; Van den Berghe G; Vanhorebeek I Shock; 2015 Feb; 43(2):109-16. PubMed ID: 25394242 [TBL] [Abstract][Full Text] [Related]
16. IL-18 is involved in vascular injury in end-stage renal disease patients. Porazko T; Kúzniar J; Kusztal M; Kúzniar TJ; Weyde W; Kuriata-Kordek M; Klinger M Nephrol Dial Transplant; 2009 Feb; 24(2):589-96. PubMed ID: 18775894 [TBL] [Abstract][Full Text] [Related]
17. Serum and mucosal S100 proteins, calprotectin (S100A8/S100A9) and S100A12, are elevated at diagnosis in children with inflammatory bowel disease. Leach ST; Yang Z; Messina I; Song C; Geczy CL; Cunningham AM; Day AS Scand J Gastroenterol; 2007 Nov; 42(11):1321-31. PubMed ID: 17852869 [TBL] [Abstract][Full Text] [Related]
18. Effect of circulating soluble receptor for advanced glycation end products (sRAGE) and the proinflammatory RAGE ligand (EN-RAGE, S100A12) on mortality in hemodialysis patients. Nakashima A; Carrero JJ; Qureshi AR; Miyamoto T; Anderstam B; Bárány P; Heimbürger O; Stenvinkel P; Lindholm B Clin J Am Soc Nephrol; 2010 Dec; 5(12):2213-9. PubMed ID: 20847094 [TBL] [Abstract][Full Text] [Related]